French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update

IF 2.2 4区医学 Q3 RESPIRATORY SYSTEM

Respiratory Medicine and Research Pub Date : 2023-11-01 DOI:10.1016/j.resmer.2023.101056

Isabelle Mahé , Guy Meyer , Philippe Girard , Laurent Bertoletti , Silvy Laporte , Francis Couturaud , Patrick Mismetti , Olivier Sanchez , Best Practice Guidelines for VTE Management Working Group

{"title":"French guidelines for the treatment of cancer-associated venous thromboembolism - 2023 update","authors":"Isabelle Mahé , Guy Meyer , Philippe Girard , Laurent Bertoletti , Silvy Laporte , Francis Couturaud , Patrick Mismetti , Olivier Sanchez , Best Practice Guidelines for VTE Management Working Group","doi":"10.1016/j.resmer.2023.101056","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In recent years, knowledge about cancer associated thrombosis has evolved considerably.</p></div><div><h3>Methods</h3><p>Practical guidelines were drafted on the initiative of the INNOVTE FCRIN Network, led by the French Speaking Society of Respiratory Diseases (SPLF), by a coordinating group, a writing group, and a review group, with the involvement of different scientific societies practicing in various settings. The method followed the \"Clinical Practice Guidelines\" process of the French National Authority for Health (HAS).</p></div><div><h3>Results</h3><p>After a literature review, guidelines were formulated, improved, and then validated by the working groups. These guidelines addressed multiple aspects of the disease and management from the data of available clinical trials and observational studies : epidemiology, initial treatment, treatment duration, extended treatment, recurrent thrombosis, central venous catheter thrombosis, incidental thrombosis, treatment in case of thrombocytopenia.</p></div><div><h3>Conclusion</h3><p>These evidence-based guidelines are intended to guide the practical management of patients with cancer associated thrombosis</p></div>","PeriodicalId":48479,"journal":{"name":"Respiratory Medicine and Research","volume":"84 ","pages":"Article 101056"},"PeriodicalIF":2.2000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590041223000685/pdfft?md5=79d903e5e6ac07b2283a15dae1d75de6&pid=1-s2.0-S2590041223000685-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Medicine and Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590041223000685","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 0

Abstract

Background

In recent years, knowledge about cancer associated thrombosis has evolved considerably.

Methods

Practical guidelines were drafted on the initiative of the INNOVTE FCRIN Network, led by the French Speaking Society of Respiratory Diseases (SPLF), by a coordinating group, a writing group, and a review group, with the involvement of different scientific societies practicing in various settings. The method followed the "Clinical Practice Guidelines" process of the French National Authority for Health (HAS).

Results

After a literature review, guidelines were formulated, improved, and then validated by the working groups. These guidelines addressed multiple aspects of the disease and management from the data of available clinical trials and observational studies : epidemiology, initial treatment, treatment duration, extended treatment, recurrent thrombosis, central venous catheter thrombosis, incidental thrombosis, treatment in case of thrombocytopenia.

Conclusion

These evidence-based guidelines are intended to guide the practical management of patients with cancer associated thrombosis

查看原文本刊更多论文

法国癌症相关静脉血栓栓塞症治疗指南-2023年更新。

背景：近年来，有关癌症相关血栓形成的知识有了很大的发展。方法：在法语呼吸系统疾病学会（SPLF）领导的INNOVTE FCRIN网络的倡议下，由一个协调小组、一个写作小组和一个审查小组起草了实用指南，不同的科学学会在不同的环境中进行了实践。该方法遵循了法国国家卫生局（HAS）的“临床实践指南”流程。结果：经过文献综述，制定、改进了指南，然后由工作组进行验证。这些指南从现有临床试验和观察性研究的数据中阐述了疾病和管理的多个方面：流行病学、初始治疗、治疗持续时间、延长治疗、复发性血栓形成、中心静脉导管血栓形成、偶然血栓形成、血小板减少症的治疗。结论：这些循证指南旨在指导癌症相关血栓形成患者的实际管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊